Zabdeno (monovalent ebola virus vaccine) / J&J  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zabdeno (monovalent ebola virus vaccine) / J&J
PRISM, NCT03140774: Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

Completed
N/A
126
Europe
Previously exposed to Ebola vaccine
University of Oxford, University of Glasgow
Ebola Virus Disease
07/20
07/20
NCT03820739: EBOVAC-Salone Extension

Completed
N/A
653
RoW
Follow-up, Blood sample collection
London School of Hygiene and Tropical Medicine, University of Sierra Leone, Janssen Vaccines & Prevention B.V., Institut National de la Santé Et de la Recherche Médicale, France, Universiteit Antwerpen
Ebola Virus Disease
06/22
07/22

Download Options